Unlike semaglutide (GLP1 agonist) or tirzepatide (GLP1/GIP dual agonist), retatrutide uniquely targets and activates three hormone receptors (GLP1, GIP, and glucagon) granting it a powerful tripleagonist mechanism. In a 48-week clinical trial, participants lost up to 24.2% of their body weight, with improvements also seen in cholesterol, triglycerides, and other metabolic markers
Patients most commonly pursue glutathione injections for immune support, detoxification, reduced fatigue, improved skin tone and brightness, and protection against oxidative stress and cellular aging
Piotrowska A, Raj-Koziak D, Lorens A, Skaryski H
Editor HochstrasserM
His experience includes a blend of qualitative and quantitative investment roles at Two Sigma, Norges Bank Investment Management, and Citadel
Most do a lot